Sclerosis multiplex (SM): nyitott vizsgálatok itt: Görögország

13 nyitott vizsgálatnak van helyszíne itt: Görögország. Regiszteradat; hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

NCT07299019
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Kísérleti kezelés · 3. fázis · Zenas BioPharma (USA), LLC
Henry Dunant Hospital Center, Athens · 401 General Military Hospital of Athens, Athens · Eginitio Hospital, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · Metropolitan General Hospital Healthcare Facilities Operation And Management Single Member S.A., Cholargos · General University Hospital of Larissa, Larissa
Regiszter frissítve: 2026-11-04
NCT07067463
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Kísérleti kezelés · 3. fázis · Zenas BioPharma (USA), LLC
Henry Dunant Hospital Center, Athens · Eginitio Hospital, Athens · 401 General Military Hospital of Athens, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · Metropolitan General Hospital Healthcare Facilities Operation And Management Single Member S.A., Cholargos · General University Hospital of Larissa, Larissa · St. Luke's Hospital S.A., Thessaloniki
Regiszter frissítve: 2026-11-03
2023-504358-36-00
Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis
Kísérleti kezelés · 3. fázis · Sanofi-Aventis Recherche & Developpement
University General Hospital of Ioannina, Ioannina · University General Hospital of Thessaloniki - AHEPA, Thessaloniki
Regiszter frissítve: 2026-10-28
NCT06846281
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Kísérleti kezelés · 3. fázis · Novartis Pharmaceuticals
University General Hospital Attikon, Athens · General University Hospital of Larissa, Larissa · St. Luke's Hospital S.A., Thessaloniki
Regiszter frissítve: 2026-10-26
NCT05003388
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for MS
Kísérleti kezelés · 1. fázis · The Foundation for Orthopaedics and Regenerative Medicine
Prodromos Stem Cell Institute, Athens
Regiszter frissítve: 2026-10-20
NCT07225504
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Kísérleti kezelés · 3. fázis · Novartis Pharmaceuticals
Athens · Chaïdári · Ioannina · Larissa · Thessaloniki
Regiszter frissítve: 2026-10-13
NCT07325292
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
Kísérleti kezelés · 3. fázis · Sanofi
401 General Military Hospital of Athens, Athens · University General Hospital of Ioannina, Ioannina · General University Hospital of Larissa, Larissa · University General Hospital of Thessaloniki - AHEPA, Thessaloniki
Regiszter frissítve: 2026-10-13
2024-512707-40-00
A Phase 2 Study of Obexelimab in Patients with Relapsing Multiple Sclerosis
Kísérleti kezelés · 2. fázis · Zenas Biopharma (USA) LLC
University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · General University Hospital of Larissa, Larissa
Regiszter frissítve: 2026-08-27
2025-521546-23-00
A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
Kísérleti kezelés · 3. fázis · Novartis Pharma AG
Eginitio Hospital, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · Metropolitan General Hospital Healthcare Facilities Operation And Management Single Member S.A., Cholargos · University General Hospital of Ioannina, Ioannina · General University Hospital of Larissa, Larissa · St. Luke's Hospital S.A., Thessaloniki · University General Hospital of Thessaloniki - AHEPA, Thessaloniki
Regiszter frissítve: 2026-07-30
2025-521910-24-00
Effects of CLADribine tablets on the Immune Synapse, in Relapsing Multiple Sclerosis (RMS) patients_CLADIS.
Kísérleti kezelés · 4. fázis · Aristotle University Of Thessaloniki
Papageorgiou Hospital, Thessaloniki · University General Hospital of Thessaloniki - AHEPA, Thessaloniki
Regiszter frissítve: 2026-07-03
NCT07630311
"Balance, Gait, and Motion Analysis in Multiple Sclerosis"
Kutatás · University of Patras
Division of Physical Medicine and Rehabilitation/Department of Surgery, University of Ioannina Medical School, Ioannina · Department of Physiotherapy of the School of Health Rehabilitation Sciences, University of Patras, Pátrai
Regiszter frissítve: 2026-06-24
NCT06486779
Kesimpta (Ofatumumab) in Greek Multiple Sclerosis Patients - an Observational Study
Kutatás · Novartis Pharmaceuticals
Alexandroupoli · Athens · Chaïdári · Crete Heraklion · Ioannina · Larissa · Pátrai · Thessaloniki
Regiszter frissítve: 2026-06-11
NCT04237675
Postoperative Relapses in MS Patients
Kutatás · University of Athens
Aretaieio Hospital, University of Athens, Athens · Aretaieio Hospital, Athens
Regiszter frissítve: 2020-01-23

Minden vizsgálat (Sclerosis multiplex (SM)) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek